Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Hafley

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of the American College of Cardiology|October 5, 2001
Differences in inducibility and prognosis of in-hospital versus out-of-hospital identified nonsustained ventricular tachycardia in patients with coronary artery disease: clinical and trial design implicationsL A Pires, M H Lehmann, A E Buxton, et al.
Circulation|July 27, 2001
Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunctionJ A Gomes, M E Cain, A E Buxton, et al.
The American Journal of Cardiology|March 16, 2001
Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function. MUSTT Investigators. Multicenter UnSustained Tachycardia TrialS N Singh, P Karasik, G E Hafley, et al.
JAMA|May 23, 2001
Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trialJ C O'Shea, G E Hafley, S Greenberg, et al.
Circulation|April 13, 1999
Prediction of sustained ventricular tachycardia inducible by programmed stimulation in patients with coronary artery disease. Utility of clinical variablesA E Buxton, G E Hafley, M H Lehmann, et al.
Journal of the American College of Cardiology|August 14, 2001
Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysisD G Wyse, M Talajic, G E Hafley, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of the American College of Cardiology|October 5, 2001
Differences in inducibility and prognosis of in-hospital versus out-of-hospital identified nonsustained ventricular tachycardia in patients with coronary artery disease: clinical and trial design implicationsL A Pires, M H Lehmann, A E Buxton, et al.
Circulation|July 27, 2001
Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunctionJ A Gomes, M E Cain, A E Buxton, et al.
The American Journal of Cardiology|March 16, 2001
Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function. MUSTT Investigators. Multicenter UnSustained Tachycardia TrialS N Singh, P Karasik, G E Hafley, et al.
JAMA|May 23, 2001
Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trialJ C O'Shea, G E Hafley, S Greenberg, et al.
Circulation|April 13, 1999
Prediction of sustained ventricular tachycardia inducible by programmed stimulation in patients with coronary artery disease. Utility of clinical variablesA E Buxton, G E Hafley, M H Lehmann, et al.
Journal of the American College of Cardiology|August 14, 2001
Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysisD G Wyse, M Talajic, G E Hafley, et al.
Pageof 1